The Role of Gut Microbiota and Its Metabolites in Mitigating Radiation Damage

Hong Zhu, Xin Yan, Hao Shi, Yiping Chen, Can Huang, Yue Zhou, Shiying Yan, Nan Zhang, Jia Wang, Jian Zhang, Chaoyi Han, Qian Chen, Jian Zhao, Mei CaoMicroorganisms 2025 · DOI

TL;DR

This review highlights the crucial role of the gut microbiota and its metabolites in protecting against radiation-induced intestinal damage (RIID). By understanding these complex interactions, researchers are paving the way for novel therapeutic strategies, including probiotics and fecal microbiota transplantation, to improve patient outcomes during and after radiation therapy.

What Problem Does This Paper Address?

Ionizing radiation (IR), while essential for medical treatments like radiotherapy and industrial applications, poses a significant threat to human health, particularly to the gastrointestinal tract. Radiation-induced intestinal damage (RIID) is a common and debilitating side effect, leading to a range of symptoms from diarrhea to more severe complications like fibrosis. Traditional treatments for RIID have limitations and risks. This paper addresses the need for a deeper understanding of how the gut microbiota, a complex ecosystem within our intestines, and its metabolic byproducts can be leveraged to mitigate these harmful effects, offering a more targeted and potentially safer therapeutic avenue.

Methods

This paper is a review, synthesizing existing research rather than presenting new experimental data. It draws upon a wide range of studies that have investigated:

  • Gut Microbiota Analysis: Techniques like 16S rRNA gene sequencing and shotgun metagenomics are used to profile the composition and changes in the gut microbial community in response to radiation.
  • Metabolomics: Analysis of metabolites produced by the gut microbiota to identify specific compounds involved in protective or damaging pathways.
  • In vivo and In vitro Studies: Research involving animal models and cell cultures to investigate the mechanisms of radiation damage and the protective effects of microbial interventions.
  • Clinical Observations: Studies examining patient outcomes and changes in gut microbiota in individuals undergoing radiotherapy.

The review focuses on analyzing the effects of IR on both mammalian and human gut microbiota, examining how radiation alters microbial composition and function, and how specific microbial metabolites contribute to the development or mitigation of RIID.

Datasets

Not discussed in the paper. This is a review article that syntheses existing research, rather than presenting new experimental data or analyses on specific datasets.

Key Insights and Ideas

  • Gut Microbiota as a Radiosensitive Organ: The gut microbiota is not just a passive bystander but a dynamic ecosystem highly sensitive to radiation, with significant shifts in composition and function occurring during and after exposure.
  • Metabolites as Key Mediators: Specific metabolites produced by gut bacteria, such as short-chain fatty acids (SCFAs) like butyrate and propionate, and indole derivatives, play a critical role in mitigating inflammation and maintaining the integrity of the intestinal barrier.
  • SCFAs for Barrier Integrity and Anti-inflammation: Butyrate, for instance, can promote the differentiation of regulatory T cells and enhance epithelial integrity by supporting tight junctions and mucus secretion.
  • Indoles for Immune Modulation and Repair: Indole derivatives can strengthen the intestinal barrier, reduce inflammation by inhibiting pro-inflammatory cytokines, and promote the proliferation and differentiation of intestinal stem cells, aiding in mucosal repair.
  • Dysbiosis as a Driver of RIID: Radiation-induced disruption of the gut microbiota (dysbiosis) can exacerbate intestinal damage and inflammation, highlighting the importance of restoring microbial balance.
  • Therapeutic Potential of Microbiota Modulation: Strategies like probiotics, prebiotics, antibiotics, and fecal microbiota transplantation (FMT) show promise in preventing or mitigating RIID by restoring a healthy gut ecosystem.

Key Results

The review synthesizes findings from numerous studies, indicating that:

  • Ionizing radiation directly kills gut microbes, leading to reduced diversity and abundance.
  • Specific bacterial species are more or less radiosensitive, with changes in the ratio of Firmicutes to Bacteroidetes commonly observed.
  • Metabolites like SCFAs and indoles have demonstrated protective effects in various studies, including reducing inflammatory markers, improving gut barrier function, and promoting tissue repair.
  • Therapeutic interventions like probiotics and FMT have shown positive outcomes in preclinical and some clinical settings, leading to reduced diarrhea, inflammation, and improved intestinal integrity in irradiated subjects.

Limitations and Future Work

The authors acknowledge several limitations and point towards future research directions:

  • Focus on Acute, High-Dose Radiation: Much of the existing research has focused on higher doses of acute radiation, with less understanding of the effects of low-dose, long-term radiation exposure, which is more relevant to certain occupational or environmental scenarios.
  • Complexity of Interactions: The precise mechanisms by which the gut microbiota and its metabolites interact with IR and the host immune system are still being elucidated.
  • Standardization of Therapies: While promising, therapies like FMT require further standardization in terms of donor selection, screening, and disposal protocols to ensure safety and efficacy.
  • Long-Term Efficacy: The long-term effects and stability of microbiota-based therapies need more extensive investigation.

Future research should focus on:

  • Elucidating Specific Mechanisms: Deepening the understanding of the molecular pathways involved in microbiota-mediated radioprotection.
  • Optimizing Microbiota-Based Therapies: Developing more targeted and effective probiotic formulations, FMT protocols, and potentially combination therapies.
  • Investigating Diet and Lifestyle: Exploring the role of diet and lifestyle interventions in modulating the gut microbiota to enhance intestinal health during irradiation.
  • Studying Low-Dose, Long-Term Exposure: Addressing the knowledge gap regarding the impact of chronic low-level radiation on the gut microbiome.

Summary updated

Abstract

With the widespread use of ionizing radiation (IR) in medical and industrial settings, irradiation has become increasingly common, posing significant risks to human health. Among the various organs affected, the gut is particularly sensitive to radiation-induced damage, leading to conditions such as radiation-induced intestinal damage (RIID). Recent studies have emphasized the critical role of gut microbiota and its metabolites in mitigating radiation-induced injury. This review discusses the effects of IR on the mammalian and human gut microbiota. We examine the dynamics of gut microbiota composition during and after irradiation, and emphasize the protective role of the gut flora and the metabolites in the pathophysiological mechanisms exhibited during radiation injury. In addition, this article investigates how specific metabolites, such as short-chain fatty acids and indole derivatives, may contribute to the mitigation of inflammation and promotion of gut barrier integrity. In addition, various therapeutic strategies based on modulating the gut microbiota, such as probiotics, antibiotics, and fecal microbiota transplantation, are discussed to understand their potential to prevent or mitigate RIID. Understanding the interactions between IR, gut microbiota and their metabolites provides new avenues for developing innovative therapeutic approaches to improve patient outcomes during and after radiotherapy. Future research directions could focus on optimizing microbiota-based therapies and exploring the role of diet and lifestyle in enhancing intestinal health during irradiation.
BibTeX
@inproceedings{zhu2025role,
  author = {Hong Zhu and Xin Yan and Hao Shi and Yiping Chen and Can Huang and Yue Zhou and Shiying Yan and Nan Zhang and Jia Wang and Jian Zhang and Chaoyi Han and Qian Chen and Jian Zhao and Mei Cao},
  title = {{The Role of Gut Microbiota and Its Metabolites in Mitigating Radiation Damage}},
  booktitle = {Microorganisms},
  year = {2025},
  doi = {10.3390/microorganisms13092151},
}
Figure